Details of the Drug

General Information of Drug (ID: DMORJD4)

Drug Name

AVB-500

Indication

Disease Entry	ICD 11	Status	REF
IgA nephropathy	MF8Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Protein

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
AXL receptor tyrosine kinase ligand (GAS6)	TT69QD2	GAS6_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04042623) Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Aravive.